Florida’s largest medical cannabis producer: ‘huge transition’ from opioids to medical cannabis underway
Trulieve CEO Kim Rivers told “Mad Money” host Jim Cramer that Florida patients with serious medical conditions, including post-traumatic stress disorder, are increasingly opting for medical cannabis over opioids.
“We’re seeing a huge transition,” Rivers said. “That’s actually one of our initiatives in front of the [Florida state] legislature this upcoming session, to introduce policies to say instead of only having opioids as an alternative, why not medical cannabis?”
With over 80,000 patients and 17 retail locations, Trulieve is Florida’s first and largest fully licensed medical cannabis company.
“There have been a number of recent studies that have come out that have shown that in states where medical cannabis programs are robust, the number of opioid prescriptions reduces dramatically,” Rivers continued. “We also know from just firsthand true stories, which we have on our website every Tuesday, that a number of our patients are transitioning from opioids to medical cannabis very effectively, and it’s a much safer and effective alternative.”
In a move common among cannabis companies in the United States, Trulieve executed a reverse takeover with a former mining company in Canada and went public north of the border.